Estradiol Terminated Phase 2 Trials for Prostate Cancer Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00176644Phase II Trial of Transdermal Estradiol for Hormone Refractory Prostate Cancer
NCT00459810Paclitaxel Poliglumex and Estradiol in Treating Patients With Stage IV Prostate Cancer